BioMed Technology Among Pioneering Recipients of Investment from CUHK Innovation Limited for Microbiome-based Healthcare Solutions
Summary
This valuable database continues to grow and serves as a promising cornerstone for the companys future R&D endeavors.Commercially, BioMed has established collaborations with over 200 healthcare service providers in Hong Kong and directly markets its products like E3 probiotics and EC Cream to consumers through more than 260 retail outlets under the PGut Brand. Furthermore, the company has also expanded its operations to Macau, Mainland China, and Thailand.Managing Director and Chief Investment Officer of CUHK Innovation Limited, Ms Joyce Ng, " People are essential building blocks for business success. It has joined forces with PetSpace, the leading veterinary group in Hong Kong, to conduct a large-scale research project recruiting a total of 500 felines and canines. The products are expected to launch in Q3 2024., Mr. Vincent Tsang said,"Through the support of the CUHK Innovation Limited, BioMed has fortified its capabilities in providing microbiome-based solutions for human and veterinary healthcare. Our unwavering commitment to advanced technology, scientific research, and personalized health management positions us with utmost confidence to drive innovation and deliver exceptional outcomes.